Antibody-based therapies to treat cancer may get a boost from an adjuvant that prevents cancer cells from escaping engulfment by macrophages. [Also see Report by Weiskopf et al. ]
No takes yet. Share an insight, caveat, or question.
Kershaw et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: